News and Announcements
SaaS company named once again as finalist in the Proptech Awards 2022
- Published June 02, 2022 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
The team at Properti Ai have been working hard over the last 12 months to offer an outstanding customer experience and an even more incredible product – helping Real Estate businesses across Australia and New Zealand dominate their digital patch.
We’re thrilled to announce that, once again, we’re a finalist in the Proptech Awards 2022 and we’re very much looking forward to soaking up the energy in the room at this years event.
We’ve worked with some sensational Real Estate brands over the last few years. Thank you to all of our customers for helping us achieve this milestone.
About The Company
Properti is an all in one digital marketing SaaS platform built for Real Estate agencies. Our platform creates on-brand creative for posts and campaigns across multiple social channels. Since starting in 2019, we have helped hundreds of real estate agents across Australia and New Zealand manage posts and campaigns on social media. With an established product, and revenue base we are looking to accelerate our marketing and sales operations.
In 2022 real estate agents need to dominate their digital patch to increase brand awareness and win new listings, this is where Properti comes in.
• Established revenue of $50,000 MRR
• Delivered over 100,000,000 impressions for our clients
• Over 350 agents with reach into major franchises: Ray White, LJ Hooker, Harcourts, and more!
• Proptech Association Australia – Startup Finalist Sales & Marketing 2021
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
